Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€24.07
18.10.21
€36.00
18.10.22
31.49%
17.11.21

Revenue growth >5% per year expected
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Risky balance sheet
tbackenh 
18.10.21 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€47.19
26.08.21
-
26.08.22
5.16%
17.11.21

Mori8 
26.08.21 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€47.19
26.08.21
-
26.08.22
5.16%
17.11.21

Mori8 
26.08.21 50%
buy
Adocia

Start price
Target price
Perf. (%)
€7.54
16.11.20
€10.00
16.11.21
18.04%
17.11.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
yester 
16.11.20 50%
sell
Aptevo Therapeutics Inc.

Start price
Target price
Perf. (%)
€35.20
16.11.20
-
16.11.21
-77.34%
17.11.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
WatchMen 
16.11.20 50%
buy
Innate Pharma

Start price
Target price
Perf. (%)
€4.10
15.11.20
€5.50
15.11.21
7.86%
16.11.21

Could be worthwhile Investment >10% per year
melinda 
15.11.20 50%
buy
Novo Nordisk A/S

Start price
Target price
Perf. (%)
€72.75
08.07.21
€105.00
08.07.22
36.34%
15.11.21

gerihouse 
08.07.21 80%
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€148.30
04.10.21
-
04.10.22
2.14%
15.11.21

Could be worthwhile Investment >10% per year
Some uniques
Sievi 
04.10.21 0%
buy
Valneva SE

Start price
Target price
Perf. (%)
€19.59
31.10.21
€30.00
31.10.22
8.63%
13.11.21

Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
skatcup 
31.10.21 80%
buy
Roche Holding AG GS

Start price
Target price
Perf. (%)
€246.05
11.11.21
-
11.11.22
-
12.11.21

donglengcha 
11.11.21 50%
buy
Roche Holding AG GS

Start price
Target price
Perf. (%)
€246.05
11.11.21
-
11.11.22
-
12.11.21

donglengcha 
11.11.21 50%
sell
Novavax Inc.

Start price
Target price
Perf. (%)
€117.42
20.10.21
€105.00
20.10.22
24.32%
11.11.21

Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
geldnutzer 
20.10.21 60%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€29.35
15.03.21
€50.00
15.03.22
43.43%
09.11.21

Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
Snowman 
15.03.21 80%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€29.35
15.03.21
€50.00
15.03.22
43.43%
09.11.21

Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
Snowman 
15.03.21 80%
buy
Virbac S.A.

Start price
Target price
Perf. (%)
€395.50
25.10.21
€480.00
25.10.22
1.52%
07.11.21

Could be worthwhile Investment >10% per year
melinda 
25.10.21 50%
buy
Aptevo Therapeutics Inc.

Start price
Target price
Perf. (%)
€42.00
19.11.20
€50.00
19.11.21
-67.07%
07.11.21

Could be very worthwhile Investment >20% year
marge 
19.11.20 50%
sell
Aphria Inc.

Start price
Target price
Perf. (%)
€4.70
05.11.20
-
05.11.21
170.32%
06.11.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
shadow 
05.11.20 50%
buy
Omeros Corp.

Start price
Target price
Perf. (%)
€5.21
19.10.21
-
19.10.22
19.09%
05.11.21

Could be worthwhile Investment >10% per year
Sievi 
19.10.21 0%
buy
Deciphera Pharmaceuticals

Start price
Target price
Perf. (%)
€28.40
29.09.21
€40.00
31.12.24
-67.96%
05.11.21

Could be very worthwhile Investment >20% year
IfYouCanDreamItYouCanDoIt 
29.09.21 70%
buy
BioLine RX Ltd ADR

Start price
Target price
Perf. (%)
€2.46
03.11.20
€3.50
04.11.21
-4.88%
05.11.21

Could be worthwhile Investment >10% per year
melinda 
03.11.20 50%
buy
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€3.53
03.11.20
€10.50
04.11.21
51.47%
05.11.21

Could be worthwhile Investment >10% per year
melinda 
03.11.20 50%
buy
Sorrento Therapeutics Inc.

Start price
Target price
Perf. (%)
€6.15
02.11.20
€13.00
04.11.21
-4.96%
05.11.21

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Top 10 in its market
Leading role in innovation
yester 
02.11.20 100%
buy
Bayer AG

Start price
Target price
Perf. (%)
€42.35
23.10.20
€54.00
04.11.21
17.72%
05.11.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
geldnutzer 
23.10.20 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€42.35
23.10.20
€54.00
04.11.21
17.72%
05.11.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
geldnutzer 
23.10.20 50%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€177.98
22.10.20
€170.00
04.11.21
-6.03%
05.11.21

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Rising EBIT margin expected
geldnutzer 
22.10.20 50%